EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Update on Chagas disease in Germany: retrospective analysis of Trypanosoma cruzi testing from 2019 to 2025

Sarahí Arellano Cuen, Guenter Froeschl, Camilla Rothe, Gabriela Equihua Martinez, Andreas K Lindner, Maria Cristina Moreno-Del Castillo, Eva-Maria Neurohr iD, Dennis Tappe, Martin Gabriel, Marc P Hübner, Achim Hoerauf, Mar Velarde-Rodriguez und 3 weitere

Infection · 02.11.2026

DOI: 10.1007/s15010-026-03041-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, online erschienen am 02.11.2026. Verfasst von Sarahí Arellano Cuen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwig-Maximilians-Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chagas disease (CD), caused by Trypanosoma cruzi (T. cruzi) , is a global concern due to international migration and the occurrence of non-vectorial transmission in non-endemic countries. In Germany, previous studies suggest substantial underdiagnosis. This study aimed to provide an updated analysis of T. cruzi testing in Germany between 2019 and 2025, to compare it with the period 2000–2018, and to examine whether testing activity changed following the 2022 national recommendations.

Methods

Retrospective descriptive study of T. cruzi diagnostic testing between January 2019 and December 2025 in Germany. Participating laboratories provided information on diagnostic procedures, demographic, and test results. Individuals with confirmed CD as well as their clinical management were further characterized using a questionnaire completed by attending physicians.

Results

Five laboratories that perform T. cruzi testing in Germany, performed 8,093 T. cruzi diagnostic tests in 3,874 individuals between 2019 and 2025. Of all tests performed, 169 (2.1%) were positive. After deduplication and application of the case definition, 33 CD cases were found. Among confirmed cases, the largest subgroup was women aged ≥ 50 years. Clinical data were available for 20/33 patients, most of whom had the indeterminate form of CD. Only 5/14 (35.7%) had received antiparasitic treatment. Most responding physicians reported having read the national recommendations introduced in 2022.

Conclusions

CD remains underdiagnosed in Germany despite the availability of national recommendations. Expanding targeted screening, increasing healthcare professional awareness, preventing non-vectorial transmission and improving health insurance coverage are essential to reduce the burden of CD.

Schlagwörter

Stichwörter der Autor:innen

T. cruziAwarenessChagasGermanyNon-endemicScreening

Autor:innen und Institutionen

  • Institute of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Center for International Health, University Hospital, LMU Munich, Munich, Germany.
  • Charité Center for Global Health, Institute of International Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
  • Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
  • National Reference Center for Tropical Pathogens, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

ORCID-Profile: Eva-Maria Neurohr

Förderung

  • Ludwig-Maximilians-Universität München

Zitieren

APA

Arellano Cuen, S., Froeschl, G., Rothe, C., Martinez, G. E., Lindner, A. K., Moreno-Del Castillo, M. C., Neurohr, E. M., Tappe, D., Gabriel, M., Hübner, M. P., Hoerauf, A., Velarde-Rodriguez, M., Martinez de Salazar, P., Albajar-Viñas, P., & Pritsch, M. (2026). Update on Chagas disease in Germany: retrospective analysis of Trypanosoma cruzi testing from 2019 to 2025. Infection. https://doi.org/10.1007/s15010-026-03041-0

Vancouver

Arellano Cuen S, Froeschl G, Rothe C, Martinez GE, Lindner AK, Moreno-Del Castillo MC, et al. Update on Chagas disease in Germany: retrospective analysis of Trypanosoma cruzi testing from 2019 to 2025. Infection. 2026. doi:10.1007/s15010-026-03041-0

BibTeX
@article{ArellanoCuen2026,
  author = {Arellano Cuen, Sarahí and Froeschl, Guenter and Rothe, Camilla and Martinez, Gabriela Equihua and Lindner, Andreas K and Moreno-Del Castillo, Maria Cristina and Neurohr, Eva-Maria and Tappe, Dennis and Gabriel, Martin and Hübner, Marc P and Hoerauf, Achim and Velarde-Rodriguez, Mar and Martinez de Salazar, Pablo and Albajar-Viñas, Pedro and Pritsch, Michael},
  title = {Update on Chagas disease in Germany: retrospective analysis of Trypanosoma cruzi testing from 2019 to 2025},
  journal = {Infection},
  year = {2026},
  doi = {10.1007/s15010-026-03041-0}
}
Kostenlos starten →